Ratings of the last 12 months
This list shows every rating MEQIRI has published for a stock, an ETF or a coin, and every change between Strong, Neutral and Weak. For stocks it also shows every valuation signal and its changes.
Counted from the public launch on 7 Nov 2026.
- Price target: none, MEQIRI does not give price targets.
- Fair value: for the valuation signal, that day's fair value, converted like the price. An estimate from the disclosed model, not a price target.
- Validity: until the rating or the valuation signal changes, time horizon about 12 months, recalculated every night.
- Price: last close before publication, converted into dollars at that day's ECB rate; ETFs in euros.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
14,177 entries
- Asmodee Group AB (publ)7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $18.18, $17.31
- Aspen Aerogels, Inc.7 Nov 2026Weak (first rating), Score 34, $4.91
- Asseco Business Solutions S.A.7 Nov 2026Strong (first rating), Score 80, $21.71
- Asseco Business Solutions S.A.7 Nov 2026Valuation signal Undervalued (first signal), Fair value $32.01, $21.71
- Asseco Poland S.A.7 Nov 2026Strong (first rating), Score 72, $58.16
- Asseco Poland S.A.7 Nov 2026Valuation signal Undervalued (first signal), Fair value $128.75, $58.16
- Asseco South Eastern Europe S.A.7 Nov 2026Strong (first rating), Score 76, $18.05
- Asseco South Eastern Europe S.A.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $20.66, $18.05
- Assembly Biosciences, Inc.7 Nov 2026Weak (first rating), Score 32, $20.42
- Assembly Biosciences, Inc.7 Nov 2026Valuation signal Overvalued (first signal), Fair value not computable, $20.42
- Assicurazioni Generali S.p.A.7 Nov 2026Strong (first rating), Score 77, $48.82
- Assicurazioni Generali S.p.A.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $50.55, $48.82
- Associated Banc-Corp7 Nov 2026Neutral (first rating), Score 67, $30.36
- Associated Banc-Corp7 Nov 2026Valuation signal Undervalued (first signal), Fair value $39.35, $30.36
- Assurant, Inc.7 Nov 2026Strong (first rating), Score 82, $307.00
- Assurant, Inc.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $321.26, $307.00
- Assured Guaranty Ltd.7 Nov 2026Neutral (first rating), Score 57, $73.45
- Assured Guaranty Ltd.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $71.22, $73.45
- Assystem S.A.7 Nov 2026Neutral (first rating), Score 52, $38.74
- Assystem S.A.7 Nov 2026Valuation signal Undervalued (first signal), Fair value $93.54, $38.74
- Astar7 Nov 2026Weak (first rating), Score 47, $0.01
- Astec Industries, Inc.7 Nov 2026Weak (first rating), Score 36, $35.71
- Astec Industries, Inc.7 Nov 2026Valuation signal Overvalued (first signal), Fair value $16.06, $35.71
- Astellas Pharma Inc.7 Nov 2026Strong (first rating), Score 87, $15.61
- Astellas Pharma Inc.7 Nov 2026Valuation signal Undervalued (first signal), Fair value $20.83, $15.61
- Aster7 Nov 2026Neutral (first rating), Score 55, $0.68
- Astera Labs, Inc.7 Nov 2026Neutral (first rating), Score 61, $190.71
- Astera Labs, Inc.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $168.09, $190.71
- AstraZeneca PLC7 Nov 2026Strong (first rating), Score 73, $186.43
- AstraZeneca PLC7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $200.61, $186.43
- Astrana Health, Inc.7 Nov 2026Neutral (first rating), Score 54, $34.50
- Astrana Health, Inc.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $75.02, $34.50
- Astronics Corporation7 Nov 2026Neutral (first rating), Score 57, $54.71
- Astronics Corporation7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $73.59, $54.71
- Neutral (first rating), Score 64, $23.24
- Valuation signal Overvalued (first signal), Fair value $12.79, $23.24
- Atal S.A.7 Nov 2026Neutral (first rating), Score 60, $15.38
- Atal S.A.7 Nov 2026Valuation signal Undervalued (first signal), Fair value $22.48, $15.38
- Atea ASA7 Nov 2026Neutral (first rating), Score 63, $17.54
- Atea ASA7 Nov 2026Valuation signal Undervalued (first signal), Fair value $24.10, $17.54
- Atea Pharmaceuticals, Inc.7 Nov 2026Weak (first rating), Score 34, $4.31
- Ategrity Specialty Holdings LLC7 Nov 2026Neutral (first rating), Score 68, $24.10
- Ategrity Specialty Holdings LLC7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $22.60, $24.10
- Athens International Airport S.7 Nov 2026Strong (first rating), Score 70, $13.28
- Athens International Airport S.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $10.01, $13.28
- Neutral (first rating), Score 51, $15.01
- Valuation signal Fairly valued (first signal), Fair value not meaningful, $15.01
- Ather Energy Ltd.7 Nov 2026Weak (first rating), Score 46, $19.40
- Ather Energy Ltd.7 Nov 2026Valuation signal Overvalued (first signal), Fair value not meaningful, $19.40
- AtkinsRéalis Group Inc.7 Nov 2026Neutral (first rating), Score 56, $62.63
- AtkinsRéalis Group Inc.7 Nov 2026Valuation signal Overvalued (first signal), Fair value $26.67, $62.63
- Atlanta Braves Holdings, Inc.7 Nov 2026Weak (first rating), Score 35, $55.43
- Atlanta Braves Holdings, Inc.7 Nov 2026Valuation signal Overvalued (first signal), Fair value not computable, $55.43
- Atlantic Union Bankshares Corporation7 Nov 2026Neutral (first rating), Score 69, $39.34
- Atlantic Union Bankshares Corporation7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $49.57, $39.34
- Atlanticus Holdings Corporation7 Nov 2026Strong (first rating), Score 78, $91.23
- Atlanticus Holdings Corporation7 Nov 2026Valuation signal Undervalued (first signal), Fair value $147.57, $91.23
- Atlas Copco AB7 Nov 2026Strong (first rating), Score 72, $18.64
- Atlas Copco AB7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $17.13, $18.64
- Atlas Energy Solutions Inc.7 Nov 2026Weak (first rating), Score 28, $5.41
- Atlas Energy Solutions Inc.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value not computable, $5.41
- Atlassian Corporation7 Nov 2026Neutral (first rating), Score 56, $153.68
- Atlassian Corporation7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $86.73, $153.68
- Atmos Energy Corporation7 Nov 2026Neutral (first rating), Score 58, $173.22
- Atmos Energy Corporation7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $139.78, $173.22
- Atmus Filtration Technologies Inc.7 Nov 2026Strong (first rating), Score 70, $50.60
- Atmus Filtration Technologies Inc.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $54.25, $50.60
- Atom Hoteles SOCIMI, S.A.7 Nov 2026Neutral (first rating), Score 59, $17.64
- Atom Hoteles SOCIMI, S.A.7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $13.59, $17.64
- Atos Group7 Nov 2026Neutral (first rating), Score 50, $27.71
- Atos Group7 Nov 2026Valuation signal Fairly valued (first signal), Fair value not computable, $27.71
- Atour Lifestyle Holdings Limited7 Nov 2026Strong (first rating), Score 82, $35.91
- Atour Lifestyle Holdings Limited7 Nov 2026Valuation signal Undervalued (first signal), Fair value $67.12, $35.91
- Neutral (first rating), Score 66, $6.70
- Valuation signal Fairly valued (first signal), Fair value $6.66, $6.70
- AtriCure, Inc.7 Nov 2026Neutral (first rating), Score 53, $58.54
- AtriCure, Inc.7 Nov 2026Valuation signal Overvalued (first signal), Fair value $16.73, $58.54
- Atria Oyj7 Nov 2026Neutral (first rating), Score 56, $17.93
- Atria Oyj7 Nov 2026Valuation signal Undervalued (first signal), Fair value $38.25, $17.93
- Atrium Ljungberg AB (publ)7 Nov 2026Weak (first rating), Score 43, $2.24
- Atrium Ljungberg AB (publ)7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $1.75, $2.24
- Attendo AB (publ)7 Nov 2026Neutral (first rating), Score 64, $13.21
- Attendo AB (publ)7 Nov 2026Valuation signal Fairly valued (first signal), Fair value $14.48, $13.21
- Attica Holdings S.A.7 Nov 2026Weak (first rating), Score 36, $1.53
- Attica Holdings S.A.7 Nov 2026Valuation signal Overvalued (first signal), Fair value $0.69, $1.53
- Attovia Therapeutics, Inc.7 Nov 2026Weak (first rating), Score 40, $15.27
- Aubay S.A.7 Nov 2026Neutral (first rating), Score 69, $55.32
- Aubay S.A.7 Nov 2026Valuation signal Undervalued (first signal), Fair value $84.77, $55.32
- Audax Renovables, S.A.7 Nov 2026Weak (first rating), Score 44, $1.24
- Audax Renovables, S.A.7 Nov 2026Valuation signal Overvalued (first signal), Fair value $0.68, $1.24
- Audius7 Nov 2026Neutral (first rating), Score 53, $0.01
- Auki7 Nov 2026Weak (first rating), Score 39, $0.01
- Aumann AG7 Nov 2026Neutral (first rating), Score 65, $14.51
- Aumann AG7 Nov 2026Valuation signal Undervalued (first signal), Fair value $52.43, $14.51
- Aumovio SE7 Nov 2026Weak (first rating), Score 37, $35.56
- Aumovio SE7 Nov 2026Valuation signal Fairly valued (first signal), Fair value not meaningful, $35.56
- Auna S.A.7 Nov 2026Weak (first rating), Score 42, $4.68
- Auna S.A.7 Nov 2026Valuation signal Overvalued (first signal), Fair value $1.99, $4.68
- Aura Biosciences, Inc.7 Nov 2026Weak (first rating), Score 39, $6.56
- Aura Minerals7 Nov 2026Neutral (first rating), Score 69, $77.82
| Date | Security | Rating | Before | Score | Fair value | Price |
|---|---|---|---|---|---|---|
| 7 Nov 2026 | Asmodee Group AB (publ) ASMDEE-B.ST | Valuation signalFairly valued | first signal | $18.18 | $17.31 | |
| 7 Nov 2026 | Aspen Aerogels, Inc. ASPN | Weak | first rating | 34 | $4.91 | |
| 7 Nov 2026 | Asseco Business Solutions S.A. ABS.WA | Strong | first rating | 80 | $21.71 | |
| 7 Nov 2026 | Asseco Business Solutions S.A. ABS.WA | Valuation signalUndervalued | first signal | $32.01 | $21.71 | |
| 7 Nov 2026 | Asseco Poland S.A. ACP.WA | Strong | first rating | 72 | $58.16 | |
| 7 Nov 2026 | Asseco Poland S.A. ACP.WA | Valuation signalUndervalued | first signal | $128.75 | $58.16 | |
| 7 Nov 2026 | Asseco South Eastern Europe S.A. ASE.WA | Strong | first rating | 76 | $18.05 | |
| 7 Nov 2026 | Asseco South Eastern Europe S.A. ASE.WA | Valuation signalFairly valued | first signal | $20.66 | $18.05 | |
| 7 Nov 2026 | Assembly Biosciences, Inc. ASMB | Weak | first rating | 32 | $20.42 | |
| 7 Nov 2026 | Assembly Biosciences, Inc. ASMB | Valuation signalOvervalued | first signal | not computable | $20.42 | |
| 7 Nov 2026 | Assicurazioni Generali S.p.A. G.MI | Strong | first rating | 77 | $48.82 | |
| 7 Nov 2026 | Assicurazioni Generali S.p.A. G.MI | Valuation signalFairly valued | first signal | $50.55 | $48.82 | |
| 7 Nov 2026 | Associated Banc-Corp ASB | Neutral | first rating | 67 | $30.36 | |
| 7 Nov 2026 | Associated Banc-Corp ASB | Valuation signalUndervalued | first signal | $39.35 | $30.36 | |
| 7 Nov 2026 | Assurant, Inc. AIZ | Strong | first rating | 82 | $307.00 | |
| 7 Nov 2026 | Assurant, Inc. AIZ | Valuation signalFairly valued | first signal | $321.26 | $307.00 | |
| 7 Nov 2026 | Assured Guaranty Ltd. AGO | Neutral | first rating | 57 | $73.45 | |
| 7 Nov 2026 | Assured Guaranty Ltd. AGO | Valuation signalFairly valued | first signal | $71.22 | $73.45 | |
| 7 Nov 2026 | Assystem S.A. ASY.PA | Neutral | first rating | 52 | $38.74 | |
| 7 Nov 2026 | Assystem S.A. ASY.PA | Valuation signalUndervalued | first signal | $93.54 | $38.74 | |
| 7 Nov 2026 | Astar ASTR | Weak | first rating | 47 | $0.01 | |
| 7 Nov 2026 | Astec Industries, Inc. ASTE | Weak | first rating | 36 | $35.71 | |
| 7 Nov 2026 | Astec Industries, Inc. ASTE | Valuation signalOvervalued | first signal | $16.06 | $35.71 | |
| 7 Nov 2026 | Astellas Pharma Inc. 4503.T | Strong | first rating | 87 | $15.61 | |
| 7 Nov 2026 | Astellas Pharma Inc. 4503.T | Valuation signalUndervalued | first signal | $20.83 | $15.61 | |
| 7 Nov 2026 | Aster ASTER | Neutral | first rating | 55 | $0.68 | |
| 7 Nov 2026 | Astera Labs, Inc. ALAB | Neutral | first rating | 61 | $190.71 | |
| 7 Nov 2026 | Astera Labs, Inc. ALAB | Valuation signalFairly valued | first signal | $168.09 | $190.71 | |
| 7 Nov 2026 | AstraZeneca PLC AZN | Strong | first rating | 73 | $186.43 | |
| 7 Nov 2026 | AstraZeneca PLC AZN | Valuation signalFairly valued | first signal | $200.61 | $186.43 | |
| 7 Nov 2026 | Astrana Health, Inc. ASTH | Neutral | first rating | 54 | $34.50 | |
| 7 Nov 2026 | Astrana Health, Inc. ASTH | Valuation signalFairly valued | first signal | $75.02 | $34.50 | |
| 7 Nov 2026 | Astronics Corporation ATRO | Neutral | first rating | 57 | $54.71 | |
| 7 Nov 2026 | Astronics Corporation ATRO | Valuation signalFairly valued | first signal | $73.59 | $54.71 | |
| 7 Nov 2026 | Asymchem Laboratories (Tianjin) Co., Ltd. 002821.SZ | Neutral | first rating | 64 | $23.24 | |
| 7 Nov 2026 | Asymchem Laboratories (Tianjin) Co., Ltd. 002821.SZ | Valuation signalOvervalued | first signal | $12.79 | $23.24 | |
| 7 Nov 2026 | Atal S.A. 1AT.WA | Neutral | first rating | 60 | $15.38 | |
| 7 Nov 2026 | Atal S.A. 1AT.WA | Valuation signalUndervalued | first signal | $22.48 | $15.38 | |
| 7 Nov 2026 | Atea ASA ATEA.OL | Neutral | first rating | 63 | $17.54 | |
| 7 Nov 2026 | Atea ASA ATEA.OL | Valuation signalUndervalued | first signal | $24.10 | $17.54 | |
| 7 Nov 2026 | Atea Pharmaceuticals, Inc. AVIR | Weak | first rating | 34 | $4.31 | |
| 7 Nov 2026 | Ategrity Specialty Holdings LLC ASIC | Neutral | first rating | 68 | $24.10 | |
| 7 Nov 2026 | Ategrity Specialty Holdings LLC ASIC | Valuation signalFairly valued | first signal | $22.60 | $24.10 | |
| 7 Nov 2026 | Athens International Airport S. AIA.AT | Strong | first rating | 70 | $13.28 | |
| 7 Nov 2026 | Athens International Airport S. AIA.AT | Valuation signalFairly valued | first signal | $10.01 | $13.28 | |
| 7 Nov 2026 | Athens Water Supply and Sewerage Company S.A. EYDAP.AT | Neutral | first rating | 51 | $15.01 | |
| 7 Nov 2026 | Athens Water Supply and Sewerage Company S.A. EYDAP.AT | Valuation signalFairly valued | first signal | not meaningful | $15.01 | |
| 7 Nov 2026 | Ather Energy Ltd. ATHERENERG.NS | Weak | first rating | 46 | $19.40 | |
| 7 Nov 2026 | Ather Energy Ltd. ATHERENERG.NS | Valuation signalOvervalued | first signal | not meaningful | $19.40 | |
| 7 Nov 2026 | AtkinsRéalis Group Inc. ATRL.TO | Neutral | first rating | 56 | $62.63 | |
| 7 Nov 2026 | AtkinsRéalis Group Inc. ATRL.TO | Valuation signalOvervalued | first signal | $26.67 | $62.63 | |
| 7 Nov 2026 | Atlanta Braves Holdings, Inc. BATRA | Weak | first rating | 35 | $55.43 | |
| 7 Nov 2026 | Atlanta Braves Holdings, Inc. BATRA | Valuation signalOvervalued | first signal | not computable | $55.43 | |
| 7 Nov 2026 | Atlantic Union Bankshares Corporation AUB | Neutral | first rating | 69 | $39.34 | |
| 7 Nov 2026 | Atlantic Union Bankshares Corporation AUB | Valuation signalFairly valued | first signal | $49.57 | $39.34 | |
| 7 Nov 2026 | Atlanticus Holdings Corporation ATLC | Strong | first rating | 78 | $91.23 | |
| 7 Nov 2026 | Atlanticus Holdings Corporation ATLC | Valuation signalUndervalued | first signal | $147.57 | $91.23 | |
| 7 Nov 2026 | Atlas Copco AB ATCO-A.ST | Strong | first rating | 72 | $18.64 | |
| 7 Nov 2026 | Atlas Copco AB ATCO-A.ST | Valuation signalFairly valued | first signal | $17.13 | $18.64 | |
| 7 Nov 2026 | Atlas Energy Solutions Inc. AESI | Weak | first rating | 28 | $5.41 | |
| 7 Nov 2026 | Atlas Energy Solutions Inc. AESI | Valuation signalFairly valued | first signal | not computable | $5.41 | |
| 7 Nov 2026 | Atlassian Corporation TEAM | Neutral | first rating | 56 | $153.68 | |
| 7 Nov 2026 | Atlassian Corporation TEAM | Valuation signalFairly valued | first signal | $86.73 | $153.68 | |
| 7 Nov 2026 | Atmos Energy Corporation ATO | Neutral | first rating | 58 | $173.22 | |
| 7 Nov 2026 | Atmos Energy Corporation ATO | Valuation signalFairly valued | first signal | $139.78 | $173.22 | |
| 7 Nov 2026 | Atmus Filtration Technologies Inc. ATMU | Strong | first rating | 70 | $50.60 | |
| 7 Nov 2026 | Atmus Filtration Technologies Inc. ATMU | Valuation signalFairly valued | first signal | $54.25 | $50.60 | |
| 7 Nov 2026 | Atom Hoteles SOCIMI, S.A. YATO.MC | Neutral | first rating | 59 | $17.64 | |
| 7 Nov 2026 | Atom Hoteles SOCIMI, S.A. YATO.MC | Valuation signalFairly valued | first signal | $13.59 | $17.64 | |
| 7 Nov 2026 | Atos Group ATO.PA | Neutral | first rating | 50 | $27.71 | |
| 7 Nov 2026 | Atos Group ATO.PA | Valuation signalFairly valued | first signal | not computable | $27.71 | |
| 7 Nov 2026 | Atour Lifestyle Holdings Limited ATAT | Strong | first rating | 82 | $35.91 | |
| 7 Nov 2026 | Atour Lifestyle Holdings Limited ATAT | Valuation signalUndervalued | first signal | $67.12 | $35.91 | |
| 7 Nov 2026 | Atresmedia Corporación de Medios de Comunicación, S.A. A3M.MC | Neutral | first rating | 66 | $6.70 | |
| 7 Nov 2026 | Atresmedia Corporación de Medios de Comunicación, S.A. A3M.MC | Valuation signalFairly valued | first signal | $6.66 | $6.70 | |
| 7 Nov 2026 | AtriCure, Inc. ATRC | Neutral | first rating | 53 | $58.54 | |
| 7 Nov 2026 | AtriCure, Inc. ATRC | Valuation signalOvervalued | first signal | $16.73 | $58.54 | |
| 7 Nov 2026 | Atria Oyj ATRAV.HE | Neutral | first rating | 56 | $17.93 | |
| 7 Nov 2026 | Atria Oyj ATRAV.HE | Valuation signalUndervalued | first signal | $38.25 | $17.93 | |
| 7 Nov 2026 | Atrium Ljungberg AB (publ) ATRLJ-B.ST | Weak | first rating | 43 | $2.24 | |
| 7 Nov 2026 | Atrium Ljungberg AB (publ) ATRLJ-B.ST | Valuation signalFairly valued | first signal | $1.75 | $2.24 | |
| 7 Nov 2026 | Attendo AB (publ) ATT.ST | Neutral | first rating | 64 | $13.21 | |
| 7 Nov 2026 | Attendo AB (publ) ATT.ST | Valuation signalFairly valued | first signal | $14.48 | $13.21 | |
| 7 Nov 2026 | Attica Holdings S.A. ATTICA.AT | Weak | first rating | 36 | $1.53 | |
| 7 Nov 2026 | Attica Holdings S.A. ATTICA.AT | Valuation signalOvervalued | first signal | $0.69 | $1.53 | |
| 7 Nov 2026 | Attovia Therapeutics, Inc. ATTO | Weak | first rating | 40 | $15.27 | |
| 7 Nov 2026 | Aubay S.A. AUB.PA | Neutral | first rating | 69 | $55.32 | |
| 7 Nov 2026 | Aubay S.A. AUB.PA | Valuation signalUndervalued | first signal | $84.77 | $55.32 | |
| 7 Nov 2026 | Audax Renovables, S.A. ADX.MC | Weak | first rating | 44 | $1.24 | |
| 7 Nov 2026 | Audax Renovables, S.A. ADX.MC | Valuation signalOvervalued | first signal | $0.68 | $1.24 | |
| 7 Nov 2026 | Audius AUDIO | Neutral | first rating | 53 | $0.01 | |
| 7 Nov 2026 | Auki AUKI | Weak | first rating | 39 | $0.01 | |
| 7 Nov 2026 | Aumann AG AAG.DE | Neutral | first rating | 65 | $14.51 | |
| 7 Nov 2026 | Aumann AG AAG.DE | Valuation signalUndervalued | first signal | $52.43 | $14.51 | |
| 7 Nov 2026 | Aumovio SE AMV0.DE | Weak | first rating | 37 | $35.56 | |
| 7 Nov 2026 | Aumovio SE AMV0.DE | Valuation signalFairly valued | first signal | not meaningful | $35.56 | |
| 7 Nov 2026 | Auna S.A. AUNA | Weak | first rating | 42 | $4.68 | |
| 7 Nov 2026 | Auna S.A. AUNA | Valuation signalOvervalued | first signal | $1.99 | $4.68 | |
| 7 Nov 2026 | Aura Biosciences, Inc. AURA | Weak | first rating | 39 | $6.56 | |
| 7 Nov 2026 | Aura Minerals AUGO | Neutral | first rating | 69 | $77.82 |
Legal basis: Article 4(1)(i) of Delegated Regulation (EU) 2016/958.
To the disclosures